Results 211 to 220 of about 107,646 (331)

Efficacy and safety of oral decitabine/cedazuridine in the chronic myelomonocytic leukaemia subpopulations from phase 2 and 3 studies

open access: yesBritish Journal of Haematology, EarlyView.
A retrospective analysis of patients with chronic myelomonocytic leukaemia treated with oral decitabine 35 mg + cedazuridine 100 mg suggested favourable outcomes, particularly in higher risk patients. The results provide a rationale for further prospective study of oral decitabine/cedazuridine to identify subgroups of this population who would benefit ...
Michael R. Savona   +16 more
wiley   +1 more source

The anti‐CD47 antibody magrolimab with obinutuzumab and venetoclax in relapsed or refractory indolent B‐cell lymphomas

open access: yesBritish Journal of Haematology, EarlyView.
Follicular lymphoma (FL), marginal zone lymphoma (MZL), chronic lymphocytic leukaemia (CLL) and mantle cell lymphoma (MCL) are characterized by a continuous incidence of relapse and increasing resistance to therapy. Novel immunotherapy approaches are needed.
Rahul Lakhotia   +11 more
wiley   +1 more source

Listeria monocytogenes Transmission from Donated Blood to Platelet Transfusion Recipient, Italy. [PDF]

open access: yesEmerg Infect Dis, 2023
Gori M   +15 more
europepmc   +1 more source

The Effects of High Particulate Matter Levels on Platelet Recovery in Patients Receiving Prophylactic Platelet Transfusion. [PDF]

open access: yesJ Blood Med
Hantrakool S   +14 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy